Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
12-CDA, 2-chloro-2'-deoxy-ß-D-adenosine
(D00045)
[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
22-CDA, 2-chloro-2?-deoxy-ß-D-adenosine
(D00045)
[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
32-CDA, 2-chloro-2’-deoxy-ß-D-adenosine
(D00045)
[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
42-chloro-2?-deoxy-ß-D-adenosine
(D00045)
----[1] 13 💬
52-chloro-2’-deoxy-ß-D-adenosine
(D00045)
----[1] 13 💬
6Adenosine
(D00045)
[1] Adenosine[1] Adenosine (D00045) 💬 [4] ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
[13] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 13, 58, 65 💬